FluoroFinder

Executive Summary

FluoroFinder is a US-based biotechnology software company that leverages AI to streamline the design of fluorescence-based experiments for flow cytometry and microscopy. Its platform analyzes millions of marker-fluorophore combinations to recommend optimized reagent panels from a vast supplier network, significantly reducing experiment planning time, errors, and costs. Founded in 2016 and headquartered in Salt Lake City, the company operates at the intersection of diagnostics and AI/machine learning, targeting a critical pain point in life sciences research. By automating complex experimental design, FluoroFinder enables researchers to focus on discovery rather than logistics, positioning itself as an essential tool for labs worldwide. The company is private and has not disclosed funding rounds or valuation, but its presence in the biopharmguy source indicates recognition within the industry.

Upcoming Catalysts (preview)

• Q2 2026Launch of AI-driven panel optimization for multi-omics integration70% success
• Q3 2026Strategic partnership with a major flow cytometry manufacturer (e.g., BD, Thermo Fisher)60% success
• Q4 2026Expansion into clinical diagnostics with FDA-cleared panel design module50% success